Perrigo (PRGO) Cash & Equivalents (2012 - 2026)

Perrigo's (PRGO) quarterly Cash & Equivalents came in at $357.2 million in Q1 2026, down 12.86% year-on-year from $409.9 million in Q1 2025, and down 32.81% on a QoQ basis from $531.6 million in Q4 2025.

Perrigo (PRGO) Cash & Equivalents (2012 - 2026) Analysis & Trends

Perrigo (PRGO) has 15 years of Cash & Equivalents data on file, last reported at $357.2 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 12.86% year-over-year to $357.2 million in Q1 2026; TTM through Mar 2026 was $357.2 million, a 12.86% decrease from a year earlier, with the FY2025 full-year figure at $531.6 million, down 4.87% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $357.2 million, down from $531.6 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for PRGO reached as high as $2.0 billion in Q2 2022 and fell as low as $357.2 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $669.8 million across 5 years, with a median of $553.0 million in 2023.
  • On a YoY basis, Cash & Equivalents climbed as much as 317.39% in 2022 and fell as far as 77.45% in 2022.
  • Year by year, Cash & Equivalents stood at $600.7 million in 2022, then increased by 25.07% to $751.3 million in 2023, then declined by 25.62% to $558.8 million in 2024, then dropped by 4.87% to $531.6 million in 2025, then plunged by 32.81% to $357.2 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $357.2 million in Q1 2026, $531.6 million in Q4 2025, and $432.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.28 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn 357.20 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 357.20 Mn
Dec 31, 2025 531.60 Mn
Sep 27, 2025 432.10 Mn
Jun 28, 2025 454.20 Mn
Mar 29, 2025 409.90 Mn
Dec 31, 2024 558.80 Mn
Sep 28, 2024 1.46 Bn
Jun 29, 2024 542.80 Mn
Mar 30, 2024 658.50 Mn
Dec 31, 2023 751.30 Mn
Sep 30, 2023 598.30 Mn
Jul 1, 2023 555.20 Mn
Apr 1, 2023 553.00 Mn
Dec 31, 2022 600.70 Mn
Oct 1, 2022 468.70 Mn
Jul 2, 2022 485.30 Mn
Apr 2, 2022 1.97 Bn
Dec 31, 2021 1.86 Bn
Oct 2, 2021 2.08 Bn
Jul 3, 2021 317.50 Mn